Osaic Holdings
KYTX icon

Osaic Holdings’s Kyverna Therapeutics KYTX Stock Holding History

Osaic Holdings’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.26K Sell
725
-2,500
-78% -$20.8K ﹤0.01% 6566
2025
Q4 		$30.3K Buy
3,225
+725
+29% +$5.38K ﹤0.01% 5583
2025
Q3 		$14.8K Hold
2,500
– – ﹤0.01% 6124
2025
Q2 		$7.67K Sell
2,500
-2,500
-50% -$6.18K ﹤0.01% 6314
2025
Q1 		$9.65K Buy
5,000
+2,822
+130% +$8.34K ﹤0.01% 5803
2024
Q4 		$8.15K Sell
2,178
-2
-0.1% -$10 ﹤0.01% 5913
2024
Q3 		$10.7K Hold
2,180
– – ﹤0.01% 5781
2024
Q2 		$16.4K Buy
2,180
+180
+9% +$2.75K ﹤0.01% 5478
2024
Q1 		$49.7K Buy
+2,000
New +$55.8K ﹤0.01% 4759

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Osaic Holdings's KYTX Position: Q1 2026 in Review

Osaic Holdings reduced its Kyverna Therapeutics (KYTX) stake by 78% in Q1 2026, selling an estimated $20.8K and leaving 725 shares worth $6.26K. The position accounts for ﹤0.01% of the portfolio, ranked #6566.

Osaic Holdings first reported a position in KYTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $49.7K in Q1 2024. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Osaic Holdings held 725 shares of Kyverna Therapeutics worth $6.26K as of Q1 2026.
  • Osaic Holdings sold 2,500 Kyverna Therapeutics shares in Q1 2026, an estimated $20.8K.
  • Kyverna Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6566 holding.
  • Osaic Holdings first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Osaic Holdings's Kyverna Therapeutics position peaked at $49.7K in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.